Oliver Hedaux

About

Oliver joined Ahren in 2019 and is a member of the investment team. He is responsible for the firm’s investments in applied AI across stages with a particular focus on science, education and robotics. He serves on the Boards of several of the firm’s portfolio companies in Europe, Israel and North America. Investments he is involved with include AI21 Labs, Ambi Robotics, Bicycle Therapeutics (IPO), Bitfount, Cassidy Bio, Graphcore (acq. Softbank), Hiverge, Mentee Robotics, Micropsi Industries and Phaidra. Prior to Ahren, Oliver was Chief of Staff at a venture backed start up recognised by Nesta as the leading British diagnostic technology to combat antimicrobial resistance. Oliver holds a First-Class undergraduate degree in Biochemistry from the University of Exeter.